Literature DB >> 16731950

Second-site revertants of a Semliki Forest virus fusion-block mutation reveal the dynamics of a class II membrane fusion protein.

Chantal Chanel-Vos1, Margaret Kielian.   

Abstract

The alphavirus Semliki Forest virus (SFV) infects cells through low-pH-induced membrane fusion mediated by the E1 protein, a class II virus membrane fusion protein. During fusion, E1 inserts into target membranes via its hydrophobic fusion loop and refolds to form a stable E1 homotrimer. Mutation of a highly conserved histidine (the H230A mutation) within a loop adjacent to the fusion loop was previously shown to block SFV fusion and infection, although the mutant E1 protein still inserts into target membranes and forms a homotrimer. Here we report on second-site mutations in E1 that rescue the H230A mutant. These mutations were located in a cluster within the hinge region, at the membrane-interacting tip, and within the groove where the E1 stem is believed to pack. Together the revertants reveal specific and interconnected aspects of the fusion protein refolding reaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731950      PMCID: PMC1472568          DOI: 10.1128/JVI.00167-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Specific roles for lipids in virus fusion and exit. Examples from the alphaviruses.

Authors:  M Kielian; P K Chatterjee; D L Gibbons; Y E Lu
Journal:  Subcell Biochem       Date:  2000

2.  Placement of the structural proteins in Sindbis virus.

Authors:  Wei Zhang; Suchetana Mukhopadhyay; Sergei V Pletnev; Timothy S Baker; Richard J Kuhn; Michael G Rossmann
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Formation and characterization of the trimeric form of the fusion protein of Semliki Forest Virus.

Authors:  D L Gibbons; A Ahn; P K Chatterjee; M Kielian
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion.

Authors:  P K Chatterjee; M Vashishtha; M Kielian
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH.

Authors:  J Lescar; A Roussel; M W Wien; J Navaza; S D Fuller; G Wengler; G Wengler; F A Rey
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

6.  The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains.

Authors:  Anna Ahn; Don L Gibbons; Margaret Kielian
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Novel mutations that control the sphingolipid and cholesterol dependence of the Semliki Forest virus fusion protein.

Authors:  Prodyot K Chatterjee; Christina H Eng; Margaret Kielian
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Differential roles of two conserved glycine residues in the fusion peptide of Semliki Forest virus.

Authors:  S G Shome; M Kielian
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

Review 9.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

10.  Molecular dissection of the Semliki Forest virus homotrimer reveals two functionally distinct regions of the fusion protein.

Authors:  Don L Gibbons; Margaret Kielian
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

View more
  21 in total

1.  The interaction of alphavirus E1 protein with exogenous domain III defines stages in virus-membrane fusion.

Authors:  Gleyder Roman-Sosa; Margaret Kielian
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Functions of the stem region of the Semliki Forest virus fusion protein during virus fusion and assembly.

Authors:  Maofu Liao; Margaret Kielian
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Thermolabilizing pseudoreversions in reovirus outer-capsid protein micro 1 rescue the entry defect conferred by a thermostabilizing mutation.

Authors:  Melina A Agosto; Jason K Middleton; Elaine C Freimont; John Yin; Max L Nibert
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

4.  The role of E3 in pH protection during alphavirus assembly and exit.

Authors:  Onyinyechukwu Uchime; Whitney Fields; Margaret Kielian
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

5.  Systematic study of the genetic response of a variable virus to the introduction of deleterious mutations in a functional capsid region.

Authors:  Eva Luna; Alicia Rodríguez-Huete; Verónica Rincón; Roberto Mateo; Mauricio G Mateu
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

6.  The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein.

Authors:  Yan Zheng; Claudia Sánchez-San Martín; Zhao-ling Qin; Margaret Kielian
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Suppressor Analysis of the Fusogenic Lambda Spanins.

Authors:  Jesse Cahill; Manoj Rajaure; Ashley Holt; Russell Moreland; Chandler O'Leary; Aneesha Kulkarni; Jordan Sloan; Ry Young
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

8.  Single-Site Glycoprotein Mutants Inhibit a Late Event in Sindbis Virus Assembly.

Authors:  Joseph Magliocca; Ricardo Vancini; Raquel Hernandez; Dennis T Brown
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

9.  Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

Authors:  S M de Boer; J Kortekaas; L Spel; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  A key interaction between the alphavirus envelope proteins responsible for initial dimer dissociation during fusion.

Authors:  Whitney Fields; Margaret Kielian
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.